Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-059971
Filing Date
2007-08-08
Accepted
2007-08-08 09:02:50
Documents
5
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a07-19073_110q.htm 10-Q 2360958
2 EX-31.1 a07-19073_1ex31d1.htm EX-31.1 7032
3 EX-31.2 a07-19073_1ex31d2.htm EX-31.2 7030
4 EX-32.1 a07-19073_1ex32d1.htm EX-32.1 6001
5 EX-32.2 a07-19073_1ex32d2.htm EX-32.2 6025
  Complete submission text file 0001104659-07-059971.txt   2388776
Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 071033714
SIC: 2834 Pharmaceutical Preparations